Zobrazeno 1 - 5
of 5
pro vyhledávání: '"M K Lamberts"'
Publikováno v:
European Heart Journal. 43
Background Percutaneous left atrial appendage occlusion (LAAO) is increasingly used for stroke prevention in high-risk patients with atrial fibrillation and contraindication for oral anticoagulation. However, studies evaluating comorbidities and mort
Autor:
A Holt, J E Strange, P V Rasmussen, P Blanche, N Nouhravesh, M H Jensen, A M Schjerning, M Schou, C Torp-Pedersen, G H Gislason, M L Hansen, P McGettigan, M K Lamberts
Publikováno v:
European Heart Journal. 43
Background Fluid retention is a known but underappreciated side-effect of non-steroidal anti-inflammatory drug (NSAID) use. As type 2 diabetes mellitus (T2DM) has been linked to both subclinical cardiomyopathy and a decline in kidney function, short-
Autor:
A Holt, J E Strange, P V Rasmussen, P Blanche, N Nouhravesh, M H Jensen, A M Schjerning, M Schou, C Torp-Pedersen, G H Gislason, M L Hansen, P McGettigan, M K Lamberts
Publikováno v:
European Heart Journal. 43
Background Treatment with medical cannabis for chronic pain is in popular demand, and a rising number of countries allow physicians to prescribe medical cannabis for pain management. However, data on drug-safety is scarce. Studies have showed a risk
Autor:
J E Strange, A Holt, D M Christensen, G Gislason, C Torp-Pedersen, M L Hansen, M K Lamberts, M Schou, J B Olesen, E L Fosboel, L Koeber, P V Rasmussen
Publikováno v:
European Heart Journal. 43
Background Oral fluoroquinolones are commonly prescribed antibiotics. Observational studies have shown an association between fluoroquinolone-use and subsequent risk of aortic aneurysm (AA) and aortic dissection (AD) due to a potential collagen degra
Autor:
N Nouhravesh, J Strange, J Toennesen, A Holt, C F Andersen, M H Jensen, A Al-Alak, M D'Souza, D Nielsen, K H Kragholm, E L Fosboel, M Schou, M K Lamberts
Publikováno v:
European Heart Journal. 43
Background Survival of patients with cardiovascular disease and cancers has increased due to improved treatments. However, the prognosis of acute coronary syndrome (ACS) in cancer patients is widely unknown, challenging clinical decision-making. Purp